dc.contributor.author | Sepehrinezhad, Ali | |
dc.contributor.author | Shahbazi, Ali | |
dc.contributor.author | Negah, Sajad Sahab | |
dc.date.accessioned | 2020-06-03T14:23:03Z | |
dc.date.available | 2020-06-03T14:23:03Z | |
dc.date.issued | 2020-05-16 | |
dc.identifier.uri | https://doi.org/10.1007/s13365-020-00851-2 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/1688 | |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to provide a precise insight for future studies. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Infectious Diseases | en_US |
dc.subject | Nervous System | en_US |
dc.title | COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review | en_US |
eihealth.country | Others | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.category | Candidate therapeutics RD | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | Journal of NeuroVirology | en_US |